Healthcare Case Studies Type:

Call for healthcare professionals: exploring bereavement and emotional support for those affected by fatal or near-fatal anaphylaxis 25th March 2025

Anaphylaxis can have a devastating emotional impact on individuals and/or families when it results in a fatal or near-fatal event. Anaphylaxis UK, in collaboration with the University of Surrey, is conducting a service evaluation to better understand how healthcare professionals

Read more
New international consensus report on anaphylaxis management released 21st March 2025

A new consensus report on anaphylaxis has been published in The Journal of Allergy and Clinical Immunology by the Global Allergy and Asthma Excellence Network (GA2LEN). This report, developed by an international panel of 46 experts from 14 countries, addresses

Read more
Real-world safety of allergen immunotherapy in adults with respiratory allergies 21st March 2025

A recent study published in Allergy examined real-world safety data on allergen immunotherapy (AIT) in adults with respiratory allergies. The study followed 1,545 patients—using both sublingual (SLIT) and subcutaneous (SCIT) routes—across eight European countries. Adverse events were recorded in 7.4% of patients,

Read more
New review highlights potential of epicutaneous immunotherapy for food allergies 21st March 2025

A new systematic review published in Clinical and Translational Allergy examines the potential of epicutaneous immunotherapy (EPIT) for treating food allergies. The study, conducted by researchers from Tampere University and Imperial College London, analysed data from 11 randomised controlled trials

Read more
New study examines how gut bacteria may influence food allergy risk in infants 18th March 2025

A recent study led by researchers at the RIKEN Centre for Integrative Medical Sciences (IMS) in Japan has provided new insights into the relationship between gut bacteria and food allergies, particularly to eggs. The findings suggest that certain types of

Read more
Promising results from Phase 1 trials of novel peanut allergy vaccine suggest potential for future therapy 14th February 2025

A Phase 1 clinical trial led by Imperial College London has tested a novel vaccine, VLP Peanut, designed to offer long-term protection against peanut allergy. Early results suggest the vaccine is well tolerated, reduces allergic responses, and promotes immune tolerance.

Read more
Meet Professor Aziz Shiekh who studies how and why diseases occur in different groups of people 28th April 2018

In celebration of #WorldAllergyWeek, and as the NHS celebrates its 70th Birthday #NHS70, we are sharing stories from our Healthcare Professional Members about their work. Professor Aziz Shiekh specialises in the field of epidemiology, the study of how often diseases occur in

Read more
Meet former army combat medic David Holden who now puts his skills to use teaching first aid 27th April 2018

In celebration of #WorldAllergyWeek, and as the NHS celebrates its 70th Birthday #NHS70, we are sharing stories from our Healthcare Professional Members about their work. David previously worked as an army combat medic and whilst he was stationed in Hong Kong,

Read more
Dr Nitin Verma talks about developing Paediatric allergy services in Dubai 24th April 2018

In celebration of #WorldAllergyWeek, and as the NHS celebrates its 70th Birthday #NHS70, we thought it would be a great opportunity to showcase stories from our Healthcare Professional Members about their work. Our Healthcare Professional Membership scheme is open to

Read more